Mohamad Makhzoumi

Mohamad Makhzoumi (board member) discloses dealings in 22 companies, chiefly NeueHealth, Inc., Robinhood Markets, Inc. and Aveo Pharmaceuticals, Inc. The record holds 188 filings, for trades running from 27 June 2018 to 10 March 2026.

The open-market side counts 44 purchases for €187.8M alongside 10 sales for €1.2M. The totals exclude 1 filing filed without an amount. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 11 share grants and 12 option exercises. 2026 to date brings 2 purchases and no sales.

In size, the median ticket on the buying side is €2.0M. Clusters matter here: 40 out of 41 purchases overlapped with buying by a colleague within 30 days. Purchases made close together by different insiders form what is called a cluster. Looking at 8 purchases old enough to measure, the stock rose over the following 90 days in 38% of cases; the median change was -4.6%. They describe history only and say nothing certain about the share price ahead.

Most recently, on 12 March 2026, the filings show an open-market purchase worth €2.0M in Korro Bio, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.